Accelerate Diagnostics' Revenues Plunge | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics, formerly called Accelr8 Technology, today said that for the five months ended Dec. 31, 2012, its revenues dropped sharply on the loss of technical development fees.

The firm's Fiscal Year 2013 began on Aug. 1, 2012. In November the firm said that it would change its fiscal year to end on Dec. 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.